Table 3 Correlation between methylation and RASSF1A immunoexpression

From: Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma

 

RASSF1A methylated

RASSF1A unmethylated

Total

RASSF1A-positive immunostaining

14

12

26

RASSF1A-negative immunostaining

26

1

27

Back to article page